How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...

Recursion Pharmaceuticals (RXRX) is up ~3% Monday after reporting phase 1b/2 data on REC-4881 for familial adenomatous polyposis. Participants in the placebo-controlled study who took the allosteric ...

In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...

In Barrie's Peter Pan, Wendy sewed Peter's mischievous shadow back on his feet. Wendy saw what was incomplete and chose to ...

With students today using AI for their learning, teachers can actually teach how to use technology as a collaborative tutor to practise skills, explain complex algorithms, and provide instant feedback ...

New VentureBeat survey data: 85% of enterprises run contested AI platforms with no single owner, and only 10% can ...

Artificial intelligence has already transformed the way people work, communicate and create. But according to AI safety ...